Although previous studies have proposed IL-18 [26, 27], serum soluble intracellular adhesion molecule-1 (sICAM-1) [2], and macrophage migration inhibitory factor (MIF) [28] for AOSD activity and/or severity, there were many limitations for these markers to put into clinical utility. This evidence concerns the gene IL18 and adult-onset Still disease.